1. Home
  2. CYCC vs MXC Comparison

CYCC vs MXC Comparison

Compare CYCC & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • MXC
  • Stock Information
  • Founded
  • CYCC 1992
  • MXC 1972
  • Country
  • CYCC Malaysia
  • MXC United States
  • Employees
  • CYCC N/A
  • MXC N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • CYCC Health Care
  • MXC Energy
  • Exchange
  • CYCC Nasdaq
  • MXC Nasdaq
  • Market Cap
  • CYCC 17.5M
  • MXC 17.6M
  • IPO Year
  • CYCC N/A
  • MXC N/A
  • Fundamental
  • Price
  • CYCC $6.37
  • MXC $8.35
  • Analyst Decision
  • CYCC
  • MXC
  • Analyst Count
  • CYCC 0
  • MXC 0
  • Target Price
  • CYCC N/A
  • MXC N/A
  • AVG Volume (30 Days)
  • CYCC 82.6K
  • MXC 3.0K
  • Earning Date
  • CYCC 11-11-2025
  • MXC 11-06-2025
  • Dividend Yield
  • CYCC N/A
  • MXC 1.20%
  • EPS Growth
  • CYCC N/A
  • MXC 44.21
  • EPS
  • CYCC N/A
  • MXC 0.79
  • Revenue
  • CYCC $10,000.00
  • MXC $7,444,407.00
  • Revenue This Year
  • CYCC $137.21
  • MXC N/A
  • Revenue Next Year
  • CYCC N/A
  • MXC N/A
  • P/E Ratio
  • CYCC N/A
  • MXC $10.54
  • Revenue Growth
  • CYCC N/A
  • MXC 13.06
  • 52 Week Low
  • CYCC $3.08
  • MXC $5.89
  • 52 Week High
  • CYCC $597.60
  • MXC $16.00
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 37.28
  • MXC 49.91
  • Support Level
  • CYCC $5.92
  • MXC $8.30
  • Resistance Level
  • CYCC $8.82
  • MXC $8.82
  • Average True Range (ATR)
  • CYCC 0.58
  • MXC 0.26
  • MACD
  • CYCC -0.04
  • MXC 0.03
  • Stochastic Oscillator
  • CYCC 15.52
  • MXC 41.24

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: